Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Circulating Tumor Cells Can Provide ‘Real-time’ Information on Patient’s Current Disease State

September 28, 2010 11:31 am | by AACR | News | Comments

DENVER — Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

Novel biomarker may predict response to new VEGF receptor inhibitor

September 28, 2010 7:31 am | by EurekAlert | News | Comments

(American Association for Cancer Research) Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib.

2010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010

September 28, 2010 6:31 am | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Featuring more than 305 scientific research sessions, 594 posters and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking...

Advertisement

Daycare puts children with lung disease at risk for serious illness

September 27, 2010 12:31 pm | by EurekAlert | News | Comments

(Johns Hopkins Medical Institutions) Exposure to common viruses in daycare puts children with a chronic lung condition caused by premature birth at risk for serious respiratory infections, according to a study from Johns Hopkins Children's Center published in the October issue of Pediatrics.

Unique gastroenterology procedure developed in adults shows promise in pediatrics

September 27, 2010 12:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) The use of device-assisted enteroscopy, a technique that allows complete examination of the small bowel, may be just as successful pediatrics as it has been in adult medicine, according to a study from Nationwide Children's Hospital.

Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases

September 27, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 27 /- Amira Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for AM152, a novel LPA1 antagonist.  If accepted, the IND will enable Amira to begin Phase 1 safety...

2010 AAO-HNSF miniseminars: Monday, Sept. 27, 2010

September 27, 2010 5:33 am | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology -- Head and Neck Surgery Foundation, the largest meeting of ear, nose and throat doctors in the world, will convene Sept. 26-29, 2010, in Boston, Mass.

GE Healthcare Set to Take Share from Siemens and Philips in the $1.2 Billion US Ultrasound Market

September 27, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

TORONTO, Sept. 27 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, GE was the overall leader in the US ultrasound system market last year. Not only did the company increase its lead over Philips and Siemens in the market, but...

Advertisement

UCLA cancer researchers discover new signaling pathway that controls cell development and cancer

September 24, 2010 2:31 am | by EurekAlert | News | Comments

(University of California -- Los Angeles) Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a new cell signaling pathway that controls cell growth and development, a pathway that, when defective, helps promote the formation of several major forms of human cancer,...

Caldolor® (ibuprofen) Injection Gaining Approval on Formulary at U.S. Medical Centers

September 23, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Sept. 23 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) today announced that Caldolor® ( ibuprofen ) Injection is gaining momentum and being approved for use in a growing number of medical facilities across the country. Several key U.S. hospitals, including...

AstraZeneca Joins Rochester Initiative to Further Cardiac Safety

September 22, 2010 9:31 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Sept. 22 /PRNewswire-USNewswire/ -- AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety. The database, called the...

Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn

September 22, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 22 /- Amgen and Pfizer today announced the launch of "Psophisticated Style:  A Guide to Everyday Style and Psoriasis™," an online resource, providing a wealth of style advice specifically for people with psoriasis. Hosted by Tim Gunn, mentor to the designers on...

Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum

September 22, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Sept. 22 /- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present at the Sachs Biotech in Europe Investor Forum Wednesday, September 29, 2010 at the Radisson Blu...

Advertisement

Aeras and Crucell announce Phase II clinical trial start in Kenya

September 22, 2010 12:31 am | by EurekAlert | News | Comments

(Aeras Global TB Vaccine Foundation) Aeras and Crucell announce the start of a Phase II clinical trial in infants of the jointly developed TB vaccine candidate, AERAS-402/Crucell Ad35. The trial will test the safety and efficacy of the TB vaccine candidate in infants previously vaccinated...

NIH celebrates 10 years of research into health disparities

September 21, 2010 1:32 pm | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease,...

New therapy found for lung and skin cancer, based on suicide gene E

September 21, 2010 12:31 pm | by EurekAlert | News | Comments

(University of Granada) This coliphage gene can induce death to cells transected with it. Scientists at the University of Granada have proven that this method is not only effective in vitro (using tumor cell cultures), but also in vivo, through the use of experimental animals in which...

ImmunoGen begins clinical tests of cancer treatment

September 21, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658, co-developed with Paris pharmaceutical giant Sanofi-aventis, in treating ovarian, breast, cervical, lung and pancreatic cancers.

Nonin Medical to Introduce New Innovations at ERS 2010 Annual Congress

September 20, 2010 2:31 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Sept. 20 /- Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, today introduced new pulse oximetry products, a new clinical guidebook and a new European sales, distribution and customer service center at the European Respiratory...

Boston Scientific to buy privately held Asthmatx

September 20, 2010 6:45 am | by The Associated Press | News | Comments

Boston Scientific will buy privately held Asthmatx Inc. in a deal that could be worth more than $440 million, the medical device maker said Monday. Boston Scientific, which is based in Natick, Mass., said it will pay $193.5 million upfront in cash. It will then make additional payments of up to...

Boston Scientific to Acquire Asthmatx

September 20, 2010 4:33 am | by Boston Scientific | News | Comments

Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma

Childhood viral infection may be a cause of obesity

September 19, 2010 9:31 pm | by EurekAlert | News | Comments

(University of California -- San Diego) The emerging idea that obesity may have an infectious origin gets new support in a cross-sectional study by University of California, San Diego School of Medicine researchers who found that children exposed to a particular strain of adenovirus were...

Possible alternate therapy for adults with poorly controlled asthma

September 19, 2010 6:31 am | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) A drug commonly used for the treatment of chronic obstructive pulmonary disease successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart,...

Adding yoga to workout regime can improve health

September 18, 2010 7:31 pm | by Baylor College of Medicine | News | Comments

Implementing yoga into a workout routine can provide unique health benefits, said a Baylor College of Medicine physician and yoga enthusiast. "Yoga is a broad philosophy containing many different paths to achieve the goal of physical, mental and spiritual well-being," said Dr. Bobby...

Increasing Prevalence of Respiratory Diseases Drives Growth for Ventilators Market

September 17, 2010 7:47 am | News | Comments

Wellingborough (September 2010) – A new report from InMedica (www.in-medica.com) on the world market for ventilators and accessories, estimated that the total market was worth $2.3 billion in 2009.

Imbalanced diet and inadequate exercise may underlie asthma in children

September 16, 2010 9:34 am | by EurekAlert | News | Comments

(American Thoracic Society) Even children of a healthy weight who have an imbalanced metabolism due to poor diet or exercise may be at increased risk of asthma, according to new research, which challenges the widespread assumption that obesity itself is a risk factor for asthma.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading